166 related articles for article (PubMed ID: 3536942)
21. Marked differences in the role of O6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea.
Jansen JG; Vrieling H; van Teijlingen CM; Mohn GR; Tates AD; van Zeeland AA
Cancer Res; 1995 May; 55(9):1875-82. PubMed ID: 7728755
[TBL] [Abstract][Full Text] [Related]
22. Chronic toxicity and carcinogenicity of cytostatic N-nitroso-(2-chloroethyl) ureas after repeated intravenous application to rats.
Eisenbrand G; Habs M
Dev Toxicol Environ Sci; 1980; 8():273-8. PubMed ID: 7308028
[No Abstract] [Full Text] [Related]
23. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents.
Gibson NW; Zlotogorski C; Erickson LC
Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757
[TBL] [Abstract][Full Text] [Related]
24. Effect of alkylation with N-methyl-N-nitrosourea and N-ethyl-N-nitrosourea on the secondary structure of DNA.
Rizvi RY; Hadi SM
Biosci Rep; 1984 Sep; 4(9):729-35. PubMed ID: 6509158
[TBL] [Abstract][Full Text] [Related]
25. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
26. DNA hydroxyethylation by hydroxyethylnitrosoureas in relation to their organ specific carcinogenicity in rats.
Ludeke B; Schubert M; Yamada Y; Lijinsky W; Kleihues P
Chem Biol Interact; 1991; 79(2):207-16. PubMed ID: 1884430
[TBL] [Abstract][Full Text] [Related]
27. Induction of lacI mutations in Big Blue Rat-2 cells treated with 1-(2-hydroxyethyl)-1-nitrosourea: a model system for the analysis of mutagenic potential of the hydroxyethyl adducts produced by 1,3-bis (2-chloroethyl)-1-nitrosourea.
Sprung CN; Wang YP; Miller DL; Giannini DD; Dhananjaya N; Bodell WJ
Mutat Res; 2001 Dec; 484(1-2):77-86. PubMed ID: 11733074
[TBL] [Abstract][Full Text] [Related]
28. Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis.
Montesano R
J Supramol Struct Cell Biochem; 1981; 17(3):259-73. PubMed ID: 7328674
[TBL] [Abstract][Full Text] [Related]
29. Nitrosoureas. Modes of action and perspectives in the use of hormone receptor affinity carrier molecules.
Eisenbrand G; Berger MR; Brix HP; Fischer JE; Mühlbauer K; Nowrousian MR; Przybilski M; Schneider MR; Stahl W; Tang W
Acta Oncol; 1989; 28(2):203-11. PubMed ID: 2544212
[TBL] [Abstract][Full Text] [Related]
30. DNA repair: counteragent in mutagenesis and carcinogenesis-- accomplice in cancer therapy resistance.
Rajewsky MF; Engelbergs J; Thomale J; Schweer T
Mutat Res; 2000 Apr; 462(2-3):101-5. PubMed ID: 10767621
[TBL] [Abstract][Full Text] [Related]
31. Mutagenicity, DNA damage and DNA adduct formation by N-nitroso-2-hydroxyalkylamine and corresponding aldehydes.
Scherer G; Ludeke B; Kleihues P; Loeppky RN; Eisenbrand G
IARC Sci Publ; 1991; (105):339-42. PubMed ID: 1855876
[TBL] [Abstract][Full Text] [Related]
32. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.
Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P
Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842
[TBL] [Abstract][Full Text] [Related]
33. Comparison of DNA lesions produced by tumor-inhibitory 1,2-bis(sulfonyl)hydrazines and chloroethylnitrosoureas.
Penketh PG; Shyam K; Sartorelli AC
Biochem Pharmacol; 2000 Feb; 59(3):283-91. PubMed ID: 10609557
[TBL] [Abstract][Full Text] [Related]
34. Alkylation damage in DNA and RNA--repair mechanisms and medical significance.
Drabløs F; Feyzi E; Aas PA; Vaagbø CB; Kavli B; Bratlie MS; Peña-Diaz J; Otterlei M; Slupphaug G; Krokan HE
DNA Repair (Amst); 2004 Nov; 3(11):1389-407. PubMed ID: 15380096
[TBL] [Abstract][Full Text] [Related]
35. A chemical basis for the antitumor activity of chloroethylnitrosoureas.
Colvin M; Brundrett RB; Cowens W; Jardine I; Ludlum DB
Biochem Pharmacol; 1976 Mar; 25(6):695-9. PubMed ID: 945062
[No Abstract] [Full Text] [Related]
36. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.
Bedford P; Eisenbrand G
Cancer Res; 1984 Feb; 44(2):514-8. PubMed ID: 6229329
[TBL] [Abstract][Full Text] [Related]
37. N-Ethyl-N-nitrosourea induces mammary cancers in the pituitary-isografted mouse which are histologically and genotypically distinct from those induced by N-methyl-N-nitrosourea.
Swanson SM; Guzman RC; Tsukamoto T; Huang TT; Dougherty CD; Nandi S
Cancer Lett; 1996 Apr; 102(1-2):159-65. PubMed ID: 8603364
[TBL] [Abstract][Full Text] [Related]
38. Role of DNA repair in carcinogen-induced ras mutation.
Engelbergs J; Thomale J; Rajewsky MF
Mutat Res; 2000 May; 450(1-2):139-53. PubMed ID: 10838139
[TBL] [Abstract][Full Text] [Related]
39. Nitrosoureas lomustine, carmustine and fotemustine induced hepatotoxic perturbations in rats: biochemical, morphological and flow cytometry studies.
Laquerriere A; Raguenez-Viotte G; Paraire M; Bizzari JP; Paresy M; Fillastre JP; Hemet J
Eur J Cancer; 1991; 27(5):630-8. PubMed ID: 1828975
[TBL] [Abstract][Full Text] [Related]
40. The binding of 1-(2-hydroxyethyl)-1-nitrosourea to DNA in vitro and to DNA of thymus and marrow in C57BL mice in vivo.
Swenson DH; Petzold GL; Harbach PR
Cancer Lett; 1986 Oct; 33(1):75-81. PubMed ID: 3768862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
